PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation Reg. (EU) No 359/2012 ,
Reg. (EU) No 540/2011
Old Legislation 2009/562
Date of approval 01/07/2012 Expiration of approval 30/06/2022
RMS

Co-RMS
BE

ES
Risk Assessment EFSA
Category FU, IN, HB, NE Review Report   Confirmatory data 2016
  Approval
Type Candidate for Substitution (CfS) CfS - criteria low ADI / ARfD / AOEL
Authorisation at national level
Authorised in In progress for
BE, BG, CY, EL, ES, FR, HU, IE, IT, MT, NL, PL, PT, RO, UK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Dazomet (Methylisothiocyanate resulting from the use of dazomet and metam)
    MRLs Annex IIIA
Classification Reg. 1272/2008
Acute Tox. 4 - H302 Skin Corr. 1B - H314
Skin Sens. 1 - H317 Aquatic Acute 1 - H400
Aquatic Chronic 1 - H410  
Toxicological information
Reference values Source Remark
ADI 0.001 EFSA 15  
ARfD 0.1 EFSA 15  
AOEL 0.001 EFSA 15  
Other
Impurity MITC (methyl isothiocyanate): ADI= 0,004, ARfD= 0,03, AOEL=0,004 (EFSA ´15) 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level